BNP PARIBAS FINANCIAL MARKETS - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 37 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$192,920
-58.6%
76,253
+8.9%
0.00%
-100.0%
Q2 2023$466,160
-78.0%
69,994
-38.5%
0.00%
-66.7%
Q1 2023$2,122,948
+179.4%
113,770
+221.6%
0.00%
+200.0%
Q4 2022$759,812
-99.9%
35,373
-34.5%
0.00%0.0%
Q3 2022$637,937,000
-23.2%
53,971
-14.3%
0.00%0.0%
Q2 2022$830,980,000
-52.3%
62,953
-24.4%
0.00%
-50.0%
Q1 2022$1,741,698,000
+28.2%
83,295
+24.6%
0.00%0.0%
Q4 2021$1,358,735,000
+77.1%
66,834
+164.4%
0.00%
+100.0%
Q3 2021$767,036,000
+47.9%
25,273
+41.6%
0.00%0.0%
Q2 2021$518,692,000
+34.2%
17,849
+99.3%
0.00%0.0%
Q1 2021$386,498,000
+499.7%
8,955
+541.9%
0.00%
Q4 2020$64,449,000
-50.9%
1,395
-53.9%
0.00%
Q3 2020$131,251,000
+11.6%
3,027
+36.4%
0.00%
Q2 2020$117,629,000
+151.9%
2,219
+6.2%
0.00%
Q1 2020$46,689,000
+258.6%
2,089
+134.5%
0.00%
Q4 2019$13,018,000
+520.5%
891
+199.0%
0.00%
Q3 2019$2,098,000
+1098.9%
298
+1762.5%
0.00%
Q2 2019$175,000160.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
LUMINUS MANAGEMENT LLC 157,099$4,565,0000.66%
ACT CAPITAL MANAGEMENT, LLC 42,000$1,221,0000.63%
Knoll Capital Management, LLC 20,000$581,0000.30%
Artemis Investment Management LLP 1,193,290$34,664,0000.30%
Ghisallo Capital Management LLC 225,000$6,539,0000.25%
Monashee Investment Management LLC 60,000$1,744,0000.21%
AlphaCentric Advisors LLC 25,000$727,0000.20%
CAAS CAPITAL MANAGEMENT LP 232,285$6,750,0000.11%
AllSquare Wealth Management LLC 5,402$157,0000.09%
CNA FINANCIAL CORP 9,479$275,0000.08%
View complete list of BIOXCEL THERAPEUTICS INC shareholders